Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Goodpasture Syndrome

Autoimmune & Inflammatory

Goodpasture Syndrome Clinical Trials and Treatments

Also called anti-GBM disease, ANCA-negative vasculitis, pulmonary-renal syndrome

Goodpasture syndrome (GPS) is a rare autoimmune pulmonary-renal vasculitis characterized by autoantibodies against the alpha-3 chain of type IV collagen in basement membranes. Pathophysiology involves IgG autoantibodies depositing along the glomerular basement membrane and pulmonary alveolar basement membrane, activating complement and recruiting neutrophils causing tissue destruction. The pathologic hallmark is linear IgG deposition along basement membranes.

In plain words, Goodpasture syndrome happens when the immune system mistakenly attacks thin linings inside the lungs and kidneys. This can cause bleeding in the lungs and harm the kidneys' tiny filters that clean the blood.

Get an email when new Goodpasture Syndrome trials open or the FDA decides. Get alerts

Goodpasture Syndrome

Where treatments stand, from ClinicalTrials.gov and FDA labels

FDA review0

No decision pending. FDA calendar

FDA-approved medicines0

No medicine's current FDA label names Goodpasture Syndrome yet.

Goodpasture Syndrome has no FDA-approved medicines, 0 open or active clinical trials (0 recruiting), and no pending FDA decision.

Labels checked October 21, 2026.Download the data

More about Goodpasture Syndrome

Clinical presentation typically involves simultaneous pulmonary and renal involvement, though isolated pulmonary disease (20%) or renal disease (10%) can occur. Pulmonary involvement manifests as hemoptysis, productive cough, dyspnea, chest pain, and progressive respiratory failure. Renal involvement presents with hematuria, proteinuria, red blood cell casts, and rapidly progressive glomerulonephritis.

Keep reading about Goodpasture Syndrome

Without treatment, rapid progression to end-stage renal disease occurs within weeks to months. Histology shows crescentic glomerulonephritis with extensive fibrin deposition. Lung biopsy shows alveolar hemorrhage with linear IgG. Early diagnosis via serology (anti-GBM antibodies by ELISA), kidney biopsy with linear IgG, and chest imaging is critical as outcomes dramatically worsen with treatment delays.

What are the symptoms of Goodpasture Syndrome?

These are common symptoms of Goodpasture Syndrome, and how strong they are varies from person to person.

  • Hemoptysis and pulmonary hemorrhage
  • Dyspnea and respiratory failure
  • Hematuria and proteinuria
  • Progressive renal dysfunction
  • Anemia and fatigue
  • Constitutional symptoms including fever

Who gets Goodpasture Syndrome?

Can occur at any age but peak incidence 20-40 years with second peak in older adults over 60. Slight male predominance overall. Often triggered or exacerbated by respiratory infections (upper respiratory tract infection, influenza) or hydrocarbon exposure (smoking, pesticides).

No known ethnic or racial predisposition. Not hereditary but autoimmune etiology. Smoking significantly increases risk. Geographic variation in prevalence noted with higher rates reported in some Caucasian populations.

Next steps: find trials you might fitsee what is being testedget help payingget alerts

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Goodpasture Syndrome

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Goodpasture Syndrome resources

Reputable organizations and medical references for learning more about Goodpasture Syndrome, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Goodpasture Syndrome

This Goodpasture Syndrome clinical trial finder lists studies as they become available, with eligibility criteria in plain English. Every trial comes from ClinicalTrials.gov.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

No active clinical trials yet

Goodpasture Syndrome is a classified rare disease, but clinical trial activity for it is limited. That's part of why we track it. When a trial opens, Trial Friend will have it.

Get an email the moment a Goodpasture Syndrome trial is registered on ClinicalTrials.gov.

Goodpasture Syndrome patient communities

Facebook groups, Reddit communities and YouTube channels where Goodpasture Syndrome patients, caregivers and advocacy groups talk.

Companies developing Goodpasture Syndrome treatments

Drugmakers that list Goodpasture Syndrome in their rare disease portfolio, 1 in all.

Questions people ask about Goodpasture Syndrome